
When will gene therapy be ready for patients with age-related macular degeneration?
Age-related macular degeneration (AMD) is a leading cause of irreversible vision loss in elderly populations worldwide, that will affect almost 290 million individuals by 2040 and is projected to increase significantly due to aging demographics.1 Advanced …